Re: Comparison of pain during intravitreal dexamethasone, ranibizumab and aflibercept injection

Clin Exp Optom. 2020 Nov;103(6):934. doi: 10.1111/cxo.13028. Epub 2019 Dec 3.

Authors

Ioanna Mylona¹, Ioannis Tsinopoulos¹

Affiliation

¹ 2nd Department of Ophthalmology, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.

PMID: 31797409
DOI: 10.1111/cxo.13028

No abstract available

Publication types

Letter
Comment

MeSH terms

Dexamethasone
Humans
Pain
Ranibizumab*
Receptors, Vascular Endothelial Growth Factor*
Recombinant Fusion Proteins

Substances

Recombinant Fusion Proteins
aflibercept
Dexamethasone
Receptors, Vascular Endothelial Growth Factor
Ranibizumab